General Pharmaceuticals Market Research Reports & Industry Analysis
General Pharmaceuticals Industry Research & Market Reports
-
Omega-3 Polyunsaturated Fatty Acids (PUFAs) – A Global Market Overview
... associated with protective effects against a variety of health conditions, including cancer, birth defects, diabetes, arthritis, cognitive decline, depression, and several others. These essential fatty acids are not produced by the body in sufficient quantities ... Read More
-
Marijuana Stores
... dominate the industry. COMPETITIVE LANDSCAPE Demand is driven by demographics, public awareness of the marijuana plant's medicinal properties, and the desire for natural health treatments. Following decades of prohibition in the US, marijuana has gained ... Read More
-
Oral Solid Dosage Forms (OSDF) and Pharma Excipients
... 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Polymers, one of the segments analyzed in the report, is expected to record a 6.2% ... Read More
-
Sodium Borohydride
... CAGR of 6.3% over the analysis period 2024-2030. Pharmaceuticals, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$733.5 Million by the end of the analysis period. ... Read More
-
D-Mannose
... 3.8% over the analysis period 2024-2030. Capsule, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$592.9 Million by the end of the analysis period. Growth in ... Read More
-
Pharmerging
... 9.7% over the analysis period 2024-2030. Pharmaceutical, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in ... Read More
-
Aseptic Processing
... CAGR of 3.5% over the analysis period 2024-2030. Plastics, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$59.0 Billion by the end of the analysis period. ... Read More
-
Pharmaceutical Contract Manufacturing
... at a CAGR of 5.2% over the analysis period 2024-2030. Pharmaceutical, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$93.8 Billion by the end of the ... Read More
-
Cannabis Edibles
... CAGR of 22.0% over the analysis period 2024-2030. Solid Edibles, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$38.2 Billion by the end of the analysis ... Read More
-
Legal Marijuana
... CAGR of 22.3% over the analysis period 2024-2030. Oil & Tinctures, one of the segments analyzed in the report, is expected to record a 23.4% CAGR and reach US$89.4 Billion by the end of the ... Read More
-
Lyophilization Equipment and Services
... 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Tray Lyophilizers, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$5.0 Billion by the ... Read More
-
Downstream Processing
... CAGR of 15.6% over the analysis period 2024-2030. Purification, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$60.6 Billion by the end of the analysis period. ... Read More
-
White Oil
... CAGR of 4.4% over the analysis period 2024-2030. Personal Care, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$720.4 Million by the end of the analysis ... Read More
-
Healthcare Supply Chain Management
... 2030, growing at a CAGR of 10.2% over the analysis period 2024-2030. Software, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$2.3 Billion by the end ... Read More
-
Medical Waste Containers
... at a CAGR of 3.9% over the analysis period 2024-2030. Chemotherapy Containers, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$322.4 Million by the end of ... Read More
-
Vial Adaptors for Reconstitution Drug
... Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Polycarbonate, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion by ... Read More
-
Glutamic Acid
... CAGR of 7.9% over the analysis period 2024-2030. Food & Beverage, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$14.6 Billion by the end of the ... Read More
-
Coating Agents
... CAGR of 7.0% over the analysis period 2024-2030. The U.S. Market is Estimated at US$333.0 Million While China is Forecast to Grow at 10.5% CAGR The Coating Agents market in the U.S. is estimated at ... Read More
-
Docosahexaenoic Acid (DHA)
... at a CAGR of 10.9% over the analysis period 2024-2030. Fish Oil DHA, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$5.3 Billion by the end ... Read More
-
Natural Betaine
... CAGR of 5.8% over the analysis period 2024-2030. Food & Beverages, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.1 Billion by the end of the ... Read More
-
Sodium Alginate
... CAGR of 5.0% over the analysis period 2024-2030. Stabilizers, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$137.4 Million by the end of the analysis period. ... Read More
-
Active Pharmaceutical Ingredients (API)
... 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Innovative, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$240.8 Billion by the end ... Read More
-
Betaine
... 4.6% over the analysis period 2024-2030. Synthetic, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth in ... Read More
-
High Potency APIs (HPAPIs)
... 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Captive, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$34.8 Billion by the end ... Read More
-
Intermediate Bulk Container
... at a CAGR of 5.2% over the analysis period 2024-2030. Chemical, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$6.4 Billion by the end of the ... Read More
Research Assistance
